Dr. Gumuscu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
351 N. Sumneytown Pike
North Wales, PA 19454
Education & Training
- Children's National Hospital/George Washington UniversityFellowship, Pediatric Hematology/Oncology, 2009 - 2012
- University of Virginia Medical CenterResidency, Pediatrics, 2007 - 2009
- University of Nebraska Medical Center College of MedicineResidency, Internal Medicine/Pediatrics, 2005 - 2007
- Istanbul University FomClass of 1997
Certifications & Licensure
- VA State Medical License 2013 - 2026
- FL State Medical License 2012 - 2015
- DC State Medical License 2009 - 2013
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 9 citationsPembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head ...Jean-Pascal Machiels, Yungan Tao, Lisa Licitra, Barbara Burtness, Makoto Tahara
The Lancet. Oncology. 2024-05-01 - 1627 citationsPembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048) : a ...Barbara Burtness, Kevin J. Harrington, Richard Greil, Denis Soulières, Makoto Tahara
Lancet. 2019-11-23 - 100 citationsPembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study.Kevin J Harrington, Barbara Burtness, Richard Greil, Denis Soulières, Makoto Tahara
Journal of Clinical Oncology. 2023-02-01
Other Languages
- Turkish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: